Tang CY - Search Results

1

Everolimus in de novo liver transplant recipients: a systematic review.

Tang CY, Shen A, Wei XF, Li QD, Liu R, Deng HJ, Wu YZ, Wu ZJ. Tang CY, et al. Hepatobiliary Pancreat Dis Int. 2015 Oct;14(5):461-9. doi: 10.1016/s1499-3872(15)60419-2. Hepatobiliary Pancreat Dis Int. 2015. PMID: 26459721 Review.

2

Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Wei X, et al. Cell Signal. 2013 May;25(5):1037-43. doi: 10.1016/j.cellsig.2013.01.019. Epub 2013 Jan 30. Cell Signal. 2013. PMID: 23376496

3

Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.

Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, Wu Z. Shen A, et al. J Gastroenterol Hepatol. 2013 May;28(5):793-800. doi: 10.1111/jgh.12162. J Gastroenterol Hepatol. 2013. PMID: 23432154

4

A systematic review of sorafenib in Child-Pugh A patients with unresectable hepatocellular carcinoma.

Shen A, Tang C, Wang Y, Chen Y, Yan X, Zhang C, Liu R, Wei X, Zhu Y, Zhang H, Wu Z. Shen A, et al. J Clin Gastroenterol. 2013 Nov-Dec;47(10):871-80. doi: 10.1097/MCG.0b013e3182a87cfd. J Clin Gastroenterol. 2013. PMID: 24100749 Review.

5

Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.

Fu Y, Wei X, Tang C, Li J, Liu R, Shen A, Wu Z. Fu Y, et al. Oncol Lett. 2013 Dec;6(6):1811-1815. doi: 10.3892/ol.2013.1638. Epub 2013 Oct 21. Oncol Lett. 2013. PMID: 24260081 Free PMC article.

6

MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.

Wei X, Tang C, Lu X, Liu R, Zhou M, He D, Zheng D, Sun C, Wu Z. Wei X, et al. Oncotarget. 2015 Jul 30;6(21):18389-405. doi: 10.18632/oncotarget.4089. Oncotarget. 2015. PMID: 26158762 Free PMC article.

7

Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cells.

Hu H, Tang C, Jiang Q, Luo W, Liu J, Wei X, Liu R, Wu Z. Hu H, et al. Oncol Lett. 2015 Jul;10(1):268-272. doi: 10.3892/ol.2015.3152. Epub 2015 Apr 27. Oncol Lett. 2015. PMID: 26171012 Free PMC article.

8

Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.

He D, Guo Z, Pu JL, Zheng DF, Wei XF, Liu R, Tang CY, Wu ZJ. He D, et al. Among authors: tang cy. Int Immunopharmacol. 2016 Jun;35:201-209. doi: 10.1016/j.intimp.2016.03.032. Epub 2016 Apr 16. Int Immunopharmacol. 2016. PMID: 27064547

9

IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.

Liu R, Tang C, Shen A, Luo H, Wei X, Zheng D, Sun C, Li Z, Zhu D, Li T, Wu Z. Liu R, et al. Oncotarget. 2016 Dec 20;7(51):85079-85096. doi: 10.18632/oncotarget.13196. Oncotarget. 2016. PMID: 27835881 Free PMC article.

10

Curcumin Inhibits Heat-Induced Apoptosis by Suppressing NADPH Oxidase 2 and Activating the Akt/mTOR Signaling Pathway in Bronchial Epithelial Cells.

Peng Y, Pu J, Tang C, Wu Z. Peng Y, et al. Cell Physiol Biochem. 2017;41(5):2091-2103. doi: 10.1159/000475444. Epub 2017 Apr 17. Cell Physiol Biochem. 2017. Retraction in: Cell Physiol Biochem. 2022 Oct 31;56(5):609. doi: 10.33594/000000581. PMID: 28478460 Free article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

801 results

Search Page

Filters